North America Bacteriophages Therapy Market to 2032
Overview
The North America Bacteriophages Therapy Market is expected to reach a 31.09 USD Million by 2032 and is projected to grow at a CAGR of 8.82% from 2025 to 2032.
Revenue, 2024 (USD Million)
20.19
Forecast, 2032 (USD Million)
31.09
CAGR, 2024 - 2032
8.82%
Report Coverage
North America
North America Bacteriophages Therapy Market 2018-2032 USD Million
North America Bacteriophages Therapy Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 20.19 USD Million
- Projected Market Size (2032): 31.09 USD Million
- CAGR (2025-2032): 8.82%
Key Findings of North America Bacteriophages Therapy Market
- The North America Bacteriophages Therapy Market was valued at 20.19 USD Million in 2024.
- The North America Bacteriophages Therapy Market is likely to grow at a CAGR of 8.82% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Lytic in Type Segment accounted for the largest share of the market with a revenue of 18.72 USD Million
- The fastest growing segment Supperative Skin Infections in Application Segment grew Fastest with a CAGR of 9.51% during the forecast period from 2024 to 2032.
North America Bacteriophages Therapy Market Scope
North America Bacteriophages Therapy Market Segmentation & Scope
Distribution Channel
- Third Party Distributors
- Direct Tender
End User
- Others
- Academic Research & Institutes
- Speciality Clinics
- Hospitals
Route Of Administration
- Others
- Parenteral
- Dermal
- Oral
Application
- Lung And Pleural Infections
- Supperative Skin Infections
- Others
- Bacterial Dysentery
- Infections Of Skin And Nasal Mucosa
- Postoperative Wound Infections
Base
- Water-Soluble Jelly Base
- Sterile Broth Culture
Type
- Lysogenic
- Lytic
Target
- Salmonella
- Streptococcus
- Pseudomonas
- Others
- Escherichia coli
- Staphylococcus
North America Bacteriophages Therapy Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 20.19 USD Million |
| Market Value in 2032 | 31.09 USD Million |
| CAGR (2025-2032) | 8.82% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,End User,Route Of Administration,Application,Base,Type,Target |
Regional Insights:
-
Leading Market (2024-2032): North America, leading in terms of revenue 20.19 USD Million in 2024
- Key Country: U.S., leading in terms of revenue with value of 18.18 USD Million in 2024.
Segments and Scope
-
North America Bacteriophages Therapy Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in North America Bacteriophages Therapy Market to 2032 with a revenue of 18.12 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in North America Bacteriophages Therapy Market to 2032 with a Growth rate of 8.99 % in forecast period 2025-2032.
-
North America Bacteriophages Therapy Market to 2032, By End User
- Hospitals is the largest segment in North America Bacteriophages Therapy Market to 2032 with a revenue of 8.04 USD Million in the year 2024.
- Speciality Clinics is the Fastest growing segment in North America Bacteriophages Therapy Market to 2032 with a Growth rate of 8.46 % in forecast period 2025-2032.
-
North America Bacteriophages Therapy Market to 2032, By Route Of Administration
- Oral is the largest segment in North America Bacteriophages Therapy Market to 2032 with a revenue of 9.26 USD Million in the year 2024.
- Dermal is the Fastest growing segment in North America Bacteriophages Therapy Market to 2032 with a Growth rate of 8.50 % in forecast period 2025-2032.
-
North America Bacteriophages Therapy Market to 2032, By Application
- Postoperative Wound Infections is the largest segment in North America Bacteriophages Therapy Market to 2032 with a revenue of 7.66 USD Million in the year 2024.
- Supperative Skin Infections is the Fastest growing segment in North America Bacteriophages Therapy Market to 2032 with a Growth rate of 9.20 % in forecast period 2025-2032.
-
North America Bacteriophages Therapy Market to 2032, By Base
- Sterile Broth Culture is the largest segment in North America Bacteriophages Therapy Market to 2032 with a revenue of 14.36 USD Million in the year 2024.
- Sterile Broth Culture is the Fastest growing segment in North America Bacteriophages Therapy Market to 2032 with a Growth rate of 9.03 % in forecast period 2025-2032.
-
North America Bacteriophages Therapy Market to 2032, By Type
- Lytic is the largest segment in North America Bacteriophages Therapy Market to 2032 with a revenue of 18.72 USD Million in the year 2024.
- Lytic is the Fastest growing segment in North America Bacteriophages Therapy Market to 2032 with a Growth rate of 9.02 % in forecast period 2025-2032.
-
North America Bacteriophages Therapy Market to 2032, By Target
- Staphylococcus is the largest segment in North America Bacteriophages Therapy Market to 2032 with a revenue of 5.36 USD Million in the year 2024.
- Escherichia coli is the Fastest growing segment in North America Bacteriophages Therapy Market to 2032 with a Growth rate of 8.44 % in forecast period 2025-2032.
North America Bacteriophages Therapy Market Company Share Analysis
| Company Name |
|
||
| Microgen | |||
| MICREOS | |||
| Intralytix, Inc. | |||
| LOCUS BIOSCIENCES, INC. | |||
| Phagelux, Inc. | |||
North America Bacteriophages Therapy Market Geographical Sales Distribution, 2018-2032 USD Million
North America Bacteriophages Therapy Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The North America Bacteriophages Therapy Market is segmented based on Segmentation Distribution Channel,End User,Route Of Administration,Application,Base,Type,Target.
North America Bacteriophages Therapy Market was valued at USD 20.19(Revenue in USD Million) in 2020.
North America Bacteriophages Therapy Market is projected to grow at a CAGR of 8.82% during the forecast period of 2024 to 2032.
The Lytic segment is expected to dominate the North America Bacteriophages Therapy Market, holding a largest market share of 18.72 USD Million in 2024
North America Bacteriophages Therapy Market Scope
North America Bacteriophages Therapy Market Segmentation & Scope
Distribution Channel
- Third Party Distributors
- Direct Tender
End User
- Others
- Academic Research & Institutes
- Speciality Clinics
- Hospitals
Route Of Administration
- Others
- Parenteral
- Dermal
- Oral
Application
- Lung And Pleural Infections
- Supperative Skin Infections
- Others
- Bacterial Dysentery
- Infections Of Skin And Nasal Mucosa
- Postoperative Wound Infections
Base
- Water-Soluble Jelly Base
- Sterile Broth Culture
Type
- Lysogenic
- Lytic
Target
- Salmonella
- Streptococcus
- Pseudomonas
- Others
- Escherichia coli
- Staphylococcus
Frequently Asked Questions
The North America Bacteriophages Therapy Market is segmented based on Segmentation Distribution Channel,End User,Route Of Administration,Application,Base,Type,Target.
North America Bacteriophages Therapy Market was valued at USD 20.19(Revenue in USD Million) in 2020.
North America Bacteriophages Therapy Market is projected to grow at a CAGR of 8.82% during the forecast period of 2024 to 2032.
The estimated market value of the North America Bacteriophages Therapy Market for final year is USD 31.09 (USD Million).
North America Bacteriophages Therapy Market Company Profiling
Frequently Asked Questions
The North America Bacteriophages Therapy Market is segmented based on Segmentation Distribution Channel,End User,Route Of Administration,Application,Base,Type,Target.
North America Bacteriophages Therapy Market was valued at USD 20.19(Revenue in USD Million) in 2020.
North America Bacteriophages Therapy Market is projected to grow at a CAGR of 8.82% during the forecast period of 2024 to 2032.
The estimated market value of the North America Bacteriophages Therapy Market for final year is USD 31.09 (USD Million).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.